69436 Tympanostomy (insertion of ventilating tube) under general anesthesia
Oral Wegovy, also made by Novo Nordisk, became available for weight loss in early 2026, and Novo plans to soon release a pill form of Ozempic
For example GLP-1s are being studied for treatment of other illnesses, like cardiovascular disease, heart failure, liver disorders, and obstructive sleep apnea
64% at 1 year and 84% at 2 years in those without diabetes Risk factors of discontinuation include lower income, older age, lower weight loss, cost, among others
Supports glutathione-S-transferase (GST) activity assays, enabling quantification of phase-II detoxification kinetics